scispace - formally typeset
Y

Yukimasa Takeda

Researcher at National Institutes of Health

Publications -  22
Citations -  1250

Yukimasa Takeda is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Retinoic acid & Receptor. The author has an hindex of 17, co-authored 19 publications receiving 1045 citations. Previous affiliations of Yukimasa Takeda include Kyushu University.

Papers
More filters
Journal ArticleDOI

Retinoic acid-related orphan receptors α and γ: key regulators of lipid/glucose metabolism, inflammation, and insulin sensitivity

TL;DR: Retinoic acid-related orphan receptors RORα and RORγ may provide novel therapeutic targets in the management of obesity and associated metabolic diseases, including hepatosteatosis, adipose tissue-associated inflammation, and insulin resistance.
Journal ArticleDOI

RORγ directly regulates the circadian expression of clock genes and downstream targets in vivo

TL;DR: It is demonstrated that the lack of retinoic acid-related orphan receptor (ROR) γ or α expression in mice significantly reduced the peak expression level of Cry1, Bmal1, E4bp4, Rev-Erbα and Per2 in an ROR isotype- and tissue-selective manner without affecting the phase of their rhythmic expression.
Journal ArticleDOI

Nuclear Orphan Receptor TAK1/TR4-Deficient Mice Are Protected Against Obesity-Linked Inflammation, Hepatic Steatosis, and Insulin Resistance

TL;DR: The data reveal that TAK1 plays a critical role in the regulation of energy and lipid homeostasis, and promotes the development of metabolic syndrome.
Journal ArticleDOI

Transcriptional profiling reveals a role for RORα in regulating gene expression in obesity-associated inflammation and hepatic steatosis

TL;DR: It is demonstrated that RORα-deficient staggerer mice fed with a high-fat diet (HFD) exhibited reduced adiposity and hepatic triglyceride levels compared with wild-type littermates and were resistant to the development of hepatic steatosis, adipose-associated inflammation, and insulin resistance.